Russian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

galactorrhea/прогестерон

Ссылка сохраняется в буфер обмена
Страница 1 от 68 полученные результаты

[Levels of progesterone, estrogen, FSH and LH in galactorrhea of unknown etiology].

Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
Considering the frequent occurrence of idiopathic galactorrhea in the women of fertile age, the hormone status was investigated in 50 patients aged from 20 to 40 years. The FSH, LH, estradiol and progesterone hormones were tested. The hormone level was estimated from venous blood serum in the stage

Galactorrhea and abnormal menses associated with a long-acting progesterone.

Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться

Effect of bromo-ergocryptine on serum hPRL, hLH, hFSH, and estradiol 17-beta in women with galactorrhea-amenorrhea.

Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
Fourteen women with amenorrhea-galactorrhea were treated with bromo-ergocryptine. Serum prolactin hPRL, hLH, hFSH, estradiol 17-beta (E2), and progesterone values were determined before and during treatment. No consistent pretreatment hormonal pattern was found. During treatment hPRL levels fell in

Fetal Death Associated With Premature Mammary Gland Development and Lactation in a Mare Treated With Weekly Injections of Long-Acting Progesterone.

Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
A 14-year-old, 530-kg, multiparous, pregnant Quarter Horse mare was referred for evaluation of premature mammary gland development and lactation. The mare was in the seventh month of gestation. The mare had a history of subfertility and was receiving weekly injections of long-acting progesterone,

Prolactin secretion and biological activity in females with galactorrhoea and normal circulating prolactin concentrations at rest.

Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
Prolactin secretion and biological activity have been investigated in 20 females with persistent idiopathic galactorrhoea who had normal resting serum prolactin levels at presentation. Results were compared with those in 34 normal controls. Hyperprolactinaemia, which was persistent in one and

[Primary glucocorticoid resistance syndrome presenting as pseudo-precocious puberty and galactorrhea].

Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
METHODS Primary glucocorticoid resistance syndrome (PGRS) is a rare condition characterized by hypercortisolism without Cushing's syndrome. This report describes a 7-year-old boy of PGRS with pseudo-precocious puberty and galactorrhea as the main manifestation. His height was 135 cm and body weight

Breast engorgement and galactorrhea after preventing premature contractions with ritodrine.

Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
Breast engorgement and galactorrhea were observed in many patients receiving ritodrine treatment to delay labor due to premature contractions. In an attempt to understand the causes for these phenomena, serum prolactin, progesterone, estradiol and estriol excretion were measured in 11 women. No

Restoration of ovarian function by low nocturnal single daily doses of bromocriptine in patients with the galactorrhea-amenorrhea syndrome.

Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
Eighteen hyperprolactinemic patients with either amenorrhea or both galactorrhea and amenorrhea were treated with 2.5 mg of bromocriptine per day supplied at night. Ovulation occurred in 16 patients, and 8 wishing to conceive became pregnant. One of these patients became pregnant for a second time

Progesterone secreting Sertoli cell tumor of the ovary.

Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
A 33-year-old woman presenting with secondary amenorrhea and galactorrhea was found to have a Sertoli cell tumor of the ovary. The neoplasm also had a sex cord tumor with annular tubules (SCTAT) component. Further investigations revealed that in many respects the patient was endocrinologically

Galactorrhea-amenorrhea syndromes: etiology and treatment.

Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
Fifteen patients with galactorrhea-amenorrhea syndromes were studied before, during, and after treatment with bromergocryptine. Galactorrhea and amenorrhea were noted after pregnancy (6 patients), after oral contraceptive therapy (5 patients), and in association with pituitary adenoma (4 patients).

Galactorrhea and pituitary tumors in postpill and non-postpill secondary amenorrhea.

Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
One hundred sixty-seven women with secondary amenorrhea were observed from six months to four years. In 66 patients, the amenorrhea followed the discontinuation of oral contraceptives (postpill) while in the remaining 101 the amenorrhea was not temporally pill related (non-postpill). Galactorrhea

Effects of nocturnal hyperprolactinemia on ovarian luteal function and galactorrhea.

Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
To determine the effects of nocturnal hyperprolactinemia on luteal function and galactorrhea we studied six diurnal normoprolactinemic women with regular menstrual cycles. The diurnal serum levels of prolactin (PRL), luteinizing hormone (LH) and progesterone (Prog) and the nocturnal PRL levels at 1

[Hyper- and normoprolactinaemia with amenorrhea and galactorrhea-amenorrhea-syndrom (author's transl)].

Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
10 amenorrhea-patients and 5 galactorrhea-amenorrhea-patients were treated wi2-Br-alpha-ergocryptine (CB 154) as a specific prolactin inhibitor. Side-effects, such as headaches, dizziness, and nausea could be reduced to a minimum by delivering the drug with the meal at night. Before and under the

Treatment of galactorrhea-amenorrhea syndrome with 2-Br-alpha-ergocryptin (CB 154). Clinical response and pattern of pituitary and steriod hormones before and during therapy.

Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
2 Bromo-alpha-ergocryptine, a specific prolactin inhibitor, was administered to 9 patients suffering from galactorrhea-amenorrhea syndrome of varying aetiology. Plasma levels of FSH, LH, prolactin, total estrogens and progesterone were measured by radioimmunoassy before and after treatment

[A study on pathogenesis and treatment of normoprolactinemic galactorrhea syndrome].

Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
To investigate the pathogenesis of the normoprolactinemic galactorrhea syndrome, the response of prolactin secretion to TRH administration and the circadian profile of serum prolactin levels were examined in 13 women with galactorrhea whose resting levels of serum prolactin were lower than 25 ng/ml.
Присоединяйтесь к нашей
странице facebook

Самая полная база данных о лекарственных травах, подтвержденная наукой

  • Работает на 55 языках
  • Травяные лекарства, подтвержденные наукой
  • Распознавание трав по изображению
  • Интерактивная карта GPS - отметьте травы на месте (скоро)
  • Прочтите научные публикации, связанные с вашим поиском
  • Ищите лекарственные травы по их действию
  • Организуйте свои интересы и будьте в курсе новостей исследований, клинических испытаний и патентов

Введите симптом или заболевание и прочтите о травах, которые могут помочь, введите лекарство и узнайте о болезнях и симптомах, против которых оно применяется.
* Вся информация основана на опубликованных научных исследованиях.

Google Play badgeApp Store badge